2MD (DP001), a Single Agent in the Management of Hemodialysis Patients: A Randomized Trial

Ravi Thadhani,Julia B. Zella,Danielle C. Knutson,William J. Blaser,Lori A. Plum,Margaret Clagett-Dame,Raymond D. Buck,Hector F. DeLuca

2MD (DP001), a Single Agent in the Management of Hemodialysis Patients: A Randomized Trial

2017

Ravi Thadhani
Julia B. Zella
Danielle C. Knutson
William J. Blaser
Lori A. Plum
Margaret Clagett-Dame
Raymond D. Buck
Hector F. DeLuca

Background: Vitamin D analogs and calcimimetics are used to manage secondary hyperparathyroidism (SHPT) in dialysis patients. DP001 is an oral vitamin D analog th

Keywords:

Endocrinology
Randomized controlled trial
Dialysis
Vitamin D and neurology
Diabetes mellitus
Parathyroid hormone
Vitamin D Analog
Internal medicine
Secondary hyperparathyroidism
Hemodialysis
Medicine
single agent
Calcitriol

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations